Skip to main content
Navigate Up
Sign In
 

From the Expert: New Advances in Treatment of Systemic Scleroderma


Systemic scleroderma (SSc) is “arguably the most challenging illness” rheumatologists encounter, according to Aryeh Fischer, MD, associate professor of medicine, Division of Rheumatology, Division of Pulmonary Sciences and Critical Care Medicine, at the University of Colorado School of Medicine in Denver.

Dr. Fischer, who served as a co-investigator in theScleroderma Lung Study II (SLS II), expects “significant expansion” of therapeutic options in the coming years.1 He spoke to The Rheumatologist about the results of the study, which were published as an abstract at the 2015 ACR/ARHP Annual Meeting.

Read more